NewsFebruary 25, 2026

Announcement of Changes of Corporate Officers at PHC Holdings Corporation Effective April 1, 2026

Please be advised of the following changes in Corporate Officers at PHC Holdings Corporation (headquarters: Chiyoda-ku, Tokyo) effective April 1, 2026.

(1) Change in Responsibilities of Corporate Officers on April 1, 2026

Name	New Responsibilities from April 1, 2026	Responsibilities Until March 31, 2026
Koichiro Sato	Technology, Manufacturing, Procurement, Business Development, Medical Policy & Public Affairs Head of Diabetes Management Domain, Head of Healthcare Solutions Domain	Technology, Manufacturing, Procurement, Business Development, Medical Policy & Public Affairs Head of Diabetes Management Domain, Head of Healthcare Solutions Domain Head of BGM Business President, Ascensia Diabetes Care Holdings AG
Chikara Takauo	Head of Life Sciences Business* R&D Representative Director & Senior Executive Director, PHC Corporation	Head of Biomedical Business Director, PHC Corporation

*Upcoming Structural Change: https://www.phchd.com/global/news/2026/0225

(2) New Appointment of Corporate Officer on April 1, 2026

Position/Title	Name	Remarks
Corporate Officer	Peter Bodlund	Head of BGM Business President, Ascensia Diabetes Care Holdings AG

(3) Corporate Officers at PHC Holdings Corporation on April 1, 2026

Position/Title	Name	Role and Responsibilities
Chief Executive Officer (CEO)	Kyoko Deguchi	Group Management, Internal Audit
Chief Operating Officer (COO) Chief Strategy Officer (CSO)	Koichiro Sato	Technology, Manufacturing, Procurement, Business Development, Medical Policy & Public Affairs Head of Diabetes Management Domain Head of Healthcare Solutions Domain
Senior Executive Corporate Officer Chief Financial Officer (CFO)	Kaiju Yamaguchi	Corporate Accounting, Corporate Finance, Group Tax Investor Relations & Corporate Communications
Senior Executive Corporate Officer Chief Administrative Officer (CAO) Chief Human Resources Officer (CHRO) Chief Transformation Officer (CTO)	Ryuichi Hirashima	General Affairs, Human Resources, Legal & Compliance, Intellectual Property, Transformation, Information Technology
Executive Corporate Officer	Nobuaki Nakamura	Head of Diagnostics & Life Sciences Domain President, Representative Director, PHC Corporation
Corporate Officer	Steven Lynum	Deputy Head of Diagnostics & Life Sciences Domain Head of Pathology Business President, Epredia Holdings Ltd.
Corporate Officer	Kenichi Uchino	Head of LSIM Business Representative Director, Member of the Board President and Chief Executive Officer, LSI Medience Corporation
Corporate Officer	Chikara Takauo	Head of Life Sciences Business R&D Representative Director & Senior Executive Director, PHC Corporation
Corporate Officer	Hideaki Takahashi	Head of Healthcare IT Solution Business President, Representative Director, Wemex Corporation
Corporate Officer	Takahide Watanabe	Corporate Planning, DX Promotion, Risk Management
Corporate Officer	Peter Bodlund	Head of BGM Business President, Ascensia Diabetes Care Holdings AG